Pediatric chyme reinfusion solution for infants with double enterostomies

Reference
1 Bhat, S., Cameron, N.-R., Sharma, P., Bissett, I. P., & O’Grady, G. (2020). Chyme recycling in the management of small bowel double enterostomy in pediatric and neonatal populations: A systematic review. Clinical Nutrition ESPEN, 37, 1–8. https://doi.org/10.1016/j.clnesp.2020.03.013

Intestinal failure in neonatal and pediatric patients is associated with substantial morbidity and mortality, most commonly caused by necrotising enterocolitis1, affecting 1 in 1,000 premature babies2.

Current management includes the formation of double enterostomy and patients will often present with high-output stoma losses resulting in dehydration and malnutrition and may require ongoing parenteral nutrition support.

Baby with The Insides Neo - fistuloclysis, distal feeding, best, alternative to parenteral nutrition, fistula, ostomy, ileostomy, chyme, enteral, oral nutrition, enteromate, intestinal failure, colon cancer, bowel cancer, gut cancer, ostomy appliance, high output, chyme, dehydration, defunctioned, ileus, lars, microbiome, lower interior resection syndrome, incontinent, incontinence, gut health, reversal surgery

The Insides Neo is a purpose-built medical device for performing chyme reinfusion therapy in neonatal and pediatric patients with intestinal failure

The Insides® Neo Adapter & Plug

Couples to an EnFit syringe to empty the Chyme.

The Insides® Neo Clip

External attachment that secures the feeding tube to the ostomy appliance while it sits in the distal limb.

The Insides® Neo Housing

Connects to an EnFit gastric feeding tube intubated into the patient's distal limb

Benefits

Increase nutrient absorption

Improved surgical outcomes

Free-up nursing time

Reference
3 Henry, M. C. W., & Moss, R. L. (2008). Neonatal necrotizing enterocolits. Seminars in Pediatric Surgery, 17(2), 98–109. https://doi.org/10.1053/j.sempedsurg.2008.02.005
Reference
4 Canvasser, J., Patel, R. M., Pryor, E., Green, L., Hintz, S. R., Fagan, M., & Harrison, J. D. (2023). Long-term outcomes and life-impacts of necrotizing enterocolitis: A survey of survivors and parents. Seminars in Perinatology, 47(1), 151696. https://doi.org/10.1016/j.semperi.2022.151696

Historically, the mortality rate of necrotising enterocolitis (NEC) is as high as 50%3, making it one of the leading causes of death in preterm infants and is associated with life long morbidity and reduced quality of life4

The Insides Neo offers significant benefits compared to the current standard of care, including:

Reference
1 Bhat, S., Cameron, N.-R., Sharma, P., Bissett, I. P., & O’Grady, G. (2020). Chyme recycling in the management of small bowel double enterostomy in pediatric and neonatal populations: A systematic review. Clinical Nutrition ESPEN, 37, 1–8. https://doi.org/10.1016/j.clnesp.2020.03.013
Reference
5 Siggers, R. H., Siggers, J., Thymann, T., Boye, M., & Sangild, P. T. (2011). Nutritional modulation of the gut microbiota and immune system in preterm neonates susceptible to necrotizing enterocolitis. The Journal of Nutritional Biochemistry, 22(6), 511–521. https://doi.org/10.1016/j.jnutbio.2010.08.002

1. Nutritional & Fluid Benefits

2. Reduction in Surgical and Ostomy Complications

3. Clinical Workflow Benefits

we love the gut - The Insides Companywe love the gut - The Insides CompanyWe Love the Gut - The Insides Companywe love the gut - The Insides Companywe love the gut - The Insides CompanyWe love the gut - The Insides Company

Choose Your Language

Selecting language below will change the language for theinsides.co